View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
August 3, 2014updated 01 Oct 2021 7:02am

Tenet Healthcare acquires Emanuel Medical Center in US

US-based healthcare services provider Tenet Healthcare has, through a subsidiary, acquired the 209-bed Emanuel Medical Center (EMC) in Turlock, California.

By Pondari PremSai

Sue Micheletti Photo

US-based healthcare services provider Tenet Healthcare has, through a subsidiary, acquired the 209-bed Emanuel Medical Center (EMC) in Turlock, California.

Free Report
img

What is the Global Healthcare and Pharma Market Q2 Outlook?

Given the background of high inflation, re-emerging supply chain issues, and the widespread macro-economic implications of the Ukraine conflict, the global pharmaceutical industry is facing an entirely new set of challenges following the turbulence of the COVID-19 pandemic. GlobalData’s World Markets Healthcare (WMH) service has released its latest Q2 forecast. This report incorporates the latest thinking on the opportunities and risks this new environment presents for pharma companies. However, the pharma sector is proving resilient, and we are projecting 4.4% global growth for the year ahead. Yet it remains that the current economic picture is inverting some baseline assumptions from previous quarterly forecasts and altering which markets we expect the key growth levers to derive from. Download our latest executive summary for a snapshot view of what our clients use to formulate winning strategies.
by GlobalData
Enter your details here to receive your free Report.

Acquired from the Covenant Ministries of Benevolence, EMC will complement the healthcare services provided by two existing Tenet hospitals in the region, Doctors Medical Center of Modesto and Doctors Hospital of Manteca.

The three hospitals will enable Tenet to enhance the efficiency and coordination of healthcare delivery in local communities.

Additionally, the acquisition will allow Tenet to improve its services in the Central Valley with the addition of the Emanuel Cancer Center, which includes a partnership with Stanford Hospital and Clinics to provide radiation oncology services, five family practice and speciality clinics, and a joint venture interest in a free-standing imaging facility.

Tenet hospital operations president Britt Reynolds said: "We are pleased to add Emanuel Medical Center to our network of patient care services in California’s Central Valley, and look forward to working with the team of dedicated physicians and staff to expand healthcare services in the area."

Built in 1917, EMC is a community hospital that provides emergency, critical care, labour and delivery, pediatrics, cardiology and surgery services.

Representing the 80th hospital in Tenet’s national network and its 12th in California, EMC will retain its affiliation with the Evangelical Covenant Church and its faith-based culture and practices.

Tenet has appointed Susan Micheletti as EMC’s new chief executive officer.

In July, Tenet acquired the Texas Regional Medical Center in Sunnyvale and opened Resolute Health Hospital in New Braunfels. Last week it unveiled the DMC Heart Hospital in Detroit.

Tenet operates 80 hospitals, 189 outpatient centres and Conifer Health Solutions, a provider of business process solutions to healthcare providers.


Image: Tenet has appointed Susan Micheletti as EMC’s new chief executive officer. Photo: courtesy of Emanuel Medical Center, Inc.

Related Companies

Free Report
img

What is the Global Healthcare and Pharma Market Q2 Outlook?

Given the background of high inflation, re-emerging supply chain issues, and the widespread macro-economic implications of the Ukraine conflict, the global pharmaceutical industry is facing an entirely new set of challenges following the turbulence of the COVID-19 pandemic. GlobalData’s World Markets Healthcare (WMH) service has released its latest Q2 forecast. This report incorporates the latest thinking on the opportunities and risks this new environment presents for pharma companies. However, the pharma sector is proving resilient, and we are projecting 4.4% global growth for the year ahead. Yet it remains that the current economic picture is inverting some baseline assumptions from previous quarterly forecasts and altering which markets we expect the key growth levers to derive from. Download our latest executive summary for a snapshot view of what our clients use to formulate winning strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management